Company Data
BioSyent Inc.
Ticker
RX:CA
Current Price
$15.8 7.78%
Market Cap
$181.3M
Price Target
Refer to Report
Volume
4.7K
52wk Range
$9.2 - $15.06
Overview
Biosyent Inc is a specialty pharmaceutical company engaged in developing pharmaceutical and healthcare products. Its products include FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Aguettant System and Cysview. The company through its subsidiaries sources acquires or in-licenses pharmaceutical products and markets the products. Geographically all the activities are functioned through the region of Canada.